3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
2
Breast
2
Gynecologic
1
Gastrointestinal
1
Endocrine
1
Conditions
Colorectal Neoplasms
45
Pancreatic Neoplasms
21
Stomach Neoplasms
11
Breast Neoplasms
11
Lung Neoplasms
9
Gastrointestinal Neoplasms
9
Colonic Neoplasms
9
Prostatic Neoplasms
8
Esophageal Neoplasms
8
Rectal Neoplasms
7
Neoplasms
5
Motor Activity
5
Liver Neoplasms
5
Carcinoma, Hepatocellular
5
Urinary Bladder Neoplasms
4
Ovarian Neoplasms
4
Malnutrition
4
Carcinoma, Non-Small-Cell Lung
4
Neoplasm Metastasis
3
Small Cell Lung Carcinoma
2
Gallbladder Neoplasms
2
Frailty
2
Cholangiocarcinoma
2
Cachexia
2
Vomiting
1
Uterine Neoplasms
1
Triple Negative Breast Neoplasms
1
Sleep Disorders, Circadian Rhythm
1
Skin Neoplasms
1
Signs and Symptoms
1
Interventions
Trastuzumab
4
Psychiatric Rehabilitation
3
cediranib
2
Watchful Waiting
2
Therapeutics
2
Radiotherapy
2
Interleukin-12 Subunit p35
2
Interleukin-12
2
Docetaxel
2
Capecitabine
2
2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide
2
tipifarnib
1
sargramostim
1
palbociclib
1
orantinib
1
montanide ISA 51
1
entinostat
1
denileukin diftitox
1
X-Ray Therapy
1
Thalidomide
1
Taxes
1
Standard of Care
1
Pyridoxine
1
Propranolol
1
Physical Therapy Modalities
1
Phlebotomy
1
Pemetrexed
1
Paclitaxel
1
N-(3-chloro-4-((3-fluorobenzyl)oxy)phenyl-6-(5-((methylsulfonyl)ethyl)aminomethyl)-2-furyl)-4-quinazolinamine
1
Microscopy, Electron
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Breast Neoplasms, Male
×
Standard of Care
×
Gastrointestinal
×
Clear all
NCT02957981
2023-09-13
GEM
Georgetown University
Phase NA
Completed
63 enrolled